ATE290868T1 - Verwendung von 19-nor-vitamin-d-verbindungen zur vorbeugung von hyperphosphatemie bei nierenkrankheiten - Google Patents

Verwendung von 19-nor-vitamin-d-verbindungen zur vorbeugung von hyperphosphatemie bei nierenkrankheiten

Info

Publication number
ATE290868T1
ATE290868T1 AT96926066T AT96926066T ATE290868T1 AT E290868 T1 ATE290868 T1 AT E290868T1 AT 96926066 T AT96926066 T AT 96926066T AT 96926066 T AT96926066 T AT 96926066T AT E290868 T1 ATE290868 T1 AT E290868T1
Authority
AT
Austria
Prior art keywords
vitamin
compounds
kidney disease
analogs
pth
Prior art date
Application number
AT96926066T
Other languages
English (en)
Inventor
Hector F Deluca
Eduardo Slatopolsky
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23997158&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE290868(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE290868T1 publication Critical patent/ATE290868T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96926066T 1995-07-13 1996-07-09 Verwendung von 19-nor-vitamin-d-verbindungen zur vorbeugung von hyperphosphatemie bei nierenkrankheiten ATE290868T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/502,288 US5597815A (en) 1995-07-13 1995-07-13 Prevention of hyperphosphatemia in kidney disorder patients
PCT/US1996/011486 WO1997002826A2 (en) 1995-07-13 1996-07-09 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients

Publications (1)

Publication Number Publication Date
ATE290868T1 true ATE290868T1 (de) 2005-04-15

Family

ID=23997158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96926066T ATE290868T1 (de) 1995-07-13 1996-07-09 Verwendung von 19-nor-vitamin-d-verbindungen zur vorbeugung von hyperphosphatemie bei nierenkrankheiten

Country Status (12)

Country Link
US (1) US5597815A (de)
EP (1) EP0837681B1 (de)
JP (1) JP3255926B2 (de)
AT (1) ATE290868T1 (de)
AU (1) AU705895B2 (de)
CA (1) CA2224284C (de)
DE (1) DE69634483T2 (de)
DK (1) DK0837681T3 (de)
ES (1) ES2236742T3 (de)
NZ (1) NZ313816A (de)
PT (1) PT837681E (de)
WO (1) WO1997002826A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998290B1 (de) * 1997-06-06 2004-09-15 Wisconsin Alumni Research Foundation Verwendung von vitamin d verbindungen zur vorbeugung von transplantatabstossung
US6359152B2 (en) 1997-07-21 2002-03-19 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
US5939406A (en) * 1997-07-21 1999-08-17 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
EP1024201B1 (de) * 1999-01-27 2003-11-26 Commissariat A L'energie Atomique Microassay zur Serienanalyse der Genexpression und Anwendungen davon
WO2002017911A1 (en) * 2000-08-30 2002-03-07 Teijin Limited Parathyroid hormone production inhibitors containing vitamin d3 derivatives
US7129230B2 (en) 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
US6887897B2 (en) 2001-07-31 2005-05-03 Mission Pharmacal Company Calcium glutarate supplement and phosphorus binder
EP1583539A2 (de) * 2003-01-13 2005-10-12 Cedars-Sinai Medical Center Paricalcitol als chemotherapeutikum
US20050148557A1 (en) * 2003-07-29 2005-07-07 Jin Tian Use of Vitamin Ds to treat kidney disease
EP2076286B1 (de) * 2006-10-25 2016-03-09 Wisconsin Alumni Research Foundation Verfahren zur verminderung der absorption von phosphat mit hilfe eines anti-npt2b antikörper
WO2010083613A1 (en) * 2009-01-26 2010-07-29 Cytochroma Inc. Phosphate management with small molecules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232734A (en) * 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions
US5246925A (en) * 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
GB2229921B (en) * 1989-04-05 1992-12-16 Chugai Pharmaceutical Co Ltd Treatment for hyperparathyroidism with use of vitamin d derivatives
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds

Also Published As

Publication number Publication date
ES2236742T3 (es) 2005-07-16
NZ313816A (en) 2001-06-29
CA2224284A1 (en) 1997-01-30
DE69634483T2 (de) 2006-04-13
EP0837681B1 (de) 2005-03-16
WO1997002826A3 (en) 1997-03-13
JP3255926B2 (ja) 2002-02-12
AU705895B2 (en) 1999-06-03
PT837681E (pt) 2005-06-30
US5597815A (en) 1997-01-28
WO1997002826A2 (en) 1997-01-30
DK0837681T3 (da) 2005-06-13
CA2224284C (en) 2003-12-02
DE69634483D1 (de) 2005-04-21
AU6636496A (en) 1997-02-10
EP0837681A2 (de) 1998-04-29
MX9800342A (es) 1998-07-31
JPH11502862A (ja) 1999-03-09

Similar Documents

Publication Publication Date Title
DE69634483D1 (de) Verwendung von 19-nor-vitamin-d-verbindungen zur vorbeugung von hyperphosphatemie bei nierenkrankheiten
KAYE et al. Arrest of hyperparathyroid bone disease with dihydrotachysterol in patients undergoing chronic hemodialysis
IL139353A (en) 1alpha-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
BG105253A (en) Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl)sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy)propylcarbamate
ATE61370T1 (de) Pharmazeutische zusammensetzungen, die geminale diphosphonate enthalten.
ES270607Y (es) Implante de huesos, especialmente protesis para la articulacion de la cadera.
WO2000043402A3 (en) Inhibitors of intestinal apical membrane na/phosphate co-transportation
AU7793887A (en) Therapeutic composition comprising gamma-linolenic acid and calcium
FR2491334B1 (de)
EP2241329A3 (de) Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen
ATE370941T1 (de) Modulatoren des vitamin-d-rezeptors
BR9808233A (pt) Preparação farmacêutica
PT97337A (pt) Metodo para o tratamento de doencas neoplasticas com conjugados do acido difluoroglutamico com folatos e anti-folatos
NO965228D0 (no) Pyridylbisfosfonater for anvendelse som terapeutisk middel
NZ222434A (en) Tissue factor protein lacking its naturally associated phospholipid
ES8507349A1 (es) Una pasta para hemostasis y union temporal de defectos en casos de traumas de huesos
Lapatsanis et al. Two types of nutritional rickets in infants
ES2166800T3 (es) Procedimiento para la preparacion de o,s-acetales de 2,2-difluoroceteno sililo y o,s-esteres del acido alfa,alfa-difluoro-beta-sililoxi-1,3-dioxolan-4-propanoico.
WO2000010548A3 (en) 19-nor-vitamin d3 compounds with calcemic activity
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
EP0116628A4 (de) 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva.
HUT46842A (en) Biocompatible layered body containing calcium phosphate and method for producing same
ATA33585A (de) Doppelstocktrogbeute für die zweivölkerbetriebsweise zur gänzlichen schwarmunterbindung
BR0307021A (pt) Uso de alquilfosfocolinas no tratamento preventivo de doenças de protozoários
Willvonseder et al. Immunoreactive Parathyroid Hormone and Calcitonin in Normocalcemic Hypercalciuria

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0837681

Country of ref document: EP